These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3940171)

  • 1. Karyotypic evolution in human malignant melanoma.
    Balaban GB; Herlyn M; Clark WH; Nowell PC
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):113-22. PubMed ID: 3940171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics of human malignant melanoma and premalignant lesions.
    Balaban G; Herlyn M; Guerry D; Bartolo R; Koprowski H; Clark WH; Nowell PC
    Cancer Genet Cytogenet; 1984 Apr; 11(4):429-39. PubMed ID: 6584203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
    Richmond A; Fine R; Murray D; Lawson DH; Priest JH
    J Invest Dermatol; 1986 Mar; 86(3):295-302. PubMed ID: 3745955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia.
    Parmiter AH; Balaban G; Clark WH; Nowell PC
    Cancer Genet Cytogenet; 1988 Feb; 30(2):313-7. PubMed ID: 3422583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas.
    Cowan JM; Halaban R; Francke U
    J Natl Cancer Inst; 1988 Sep; 80(14):1159-64. PubMed ID: 3166071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution.
    Höglund M; Gisselsson D; Hansen GB; White VA; Säll T; Mitelman F; Horsman D
    Int J Cancer; 2004 Jan; 108(1):57-65. PubMed ID: 14618616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
    Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
    Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome changes in metastatic human melanoma.
    Limon J; Dal Cin P; Sait SN; Karakousis C; Sandberg AA
    Cancer Genet Cytogenet; 1988 Feb; 30(2):201-11. PubMed ID: 3422577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic findings in 21 malignant melanomas.
    Ozisik YY; Meloni AM; Altungoz O; Peier A; Karakousis C; Leong SP; Sandberg AA
    Cancer Genet Cytogenet; 1994 Oct; 77(1):69-73. PubMed ID: 7923087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonrandom chromosome changes in malignant melanoma.
    Becher R; Gibas Z; Karakousis C; Sandberg AA
    Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases.
    Nelson MA; Radmacher MD; Simon R; Aickin M; Yang J; Panda L; Emerson J; Roe D; Adair L; Thompson F; Bangert J; Leong SP; Taetle R; Salmon S; Trent J
    Cancer Genet Cytogenet; 2000 Oct; 122(2):101-9. PubMed ID: 11106819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent karyotypic abnormalities in human malignant melanomas.
    Kacker RK; Giovanella BC; Pathak S
    Anticancer Res; 1990; 10(4):859-71. PubMed ID: 2382982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution in vitro of stemlines with minimal karyotypic deviations in a human heteroploid cell line.
    Chen TR
    J Natl Cancer Inst; 1978 Aug; 61(2):277-84. PubMed ID: 277716
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas.
    Heim S; Mandahl N; Arheden K; Giovanella BC; Yim SO; Stehlin JS; Mitelman F
    Cancer Genet Cytogenet; 1988 Oct; 35(1):5-20. PubMed ID: 3180009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.
    Herlyn M; Balaban G; Bennicelli J; Guerry D; Halaban R; Herlyn D; Elder DE; Maul GG; Steplewski Z; Nowell PC
    J Natl Cancer Inst; 1985 Feb; 74(2):283-9. PubMed ID: 3856042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.
    Yang P; Farkas DL; Kirkwood JM; Abernethy JL; Edington HD; Becker D
    Mol Med; 1999 Dec; 5(12):785-94. PubMed ID: 10666478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.